255 related articles for article (PubMed ID: 15455398)
1. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
Miyata H; Chiang AC; Vinters HV
Ann Neurol; 2004 Oct; 56(4):510-9. PubMed ID: 15455398
[TBL] [Abstract][Full Text] [Related]
2. mTOR cascade activation distinguishes tubers from focal cortical dysplasia.
Baybis M; Yu J; Lee A; Golden JA; Weiner H; McKhann G; Aronica E; Crino PB
Ann Neurol; 2004 Oct; 56(4):478-87. PubMed ID: 15455405
[TBL] [Abstract][Full Text] [Related]
3. Cellular localization of metabotropic glutamate receptors in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
Boer K; Troost D; Timmermans W; Gorter JA; Spliet WG; Nellist M; Jansen F; Aronica E
Neuroscience; 2008 Sep; 156(1):203-15. PubMed ID: 18706978
[TBL] [Abstract][Full Text] [Related]
4. Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex.
Ruppe V; Dilsiz P; Reiss CS; Carlson C; Devinsky O; Zagzag D; Weiner HL; Talos DM
Epilepsia; 2014 Apr; 55(4):539-50. PubMed ID: 24512506
[TBL] [Abstract][Full Text] [Related]
5. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs).
Sugiura C; Miyata H; Ueda M; Ohama E; Vinters HV; Ohno K
Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408
[TBL] [Abstract][Full Text] [Related]
7. The mTOR pathway is activated in glial cells in mesial temporal sclerosis.
Sosunov AA; Wu X; McGovern RA; Coughlin DG; Mikell CB; Goodman RR; McKhann GM
Epilepsia; 2012 Jun; 53 Suppl 1():78-86. PubMed ID: 22612812
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
9. CD34-immunoreactive balloon cells in cortical malformations.
Fauser S; Becker A; Schulze-Bonhage A; Hildebrandt M; Tuxhorn I; Pannek HW; Lahl R; Schramm J; Blümcke I
Acta Neuropathol; 2004 Oct; 108(4):272-8. PubMed ID: 15221338
[TBL] [Abstract][Full Text] [Related]
10. Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex.
Marcotte L; Aronica E; Baybis M; Crino PB
Acta Neuropathol; 2012 May; 123(5):685-93. PubMed ID: 22327361
[TBL] [Abstract][Full Text] [Related]
11. Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia.
Ljungberg MC; Bhattacharjee MB; Lu Y; Armstrong DL; Yoshor D; Swann JW; Sheldon M; D'Arcangelo G
Ann Neurol; 2006 Oct; 60(4):420-9. PubMed ID: 16912980
[TBL] [Abstract][Full Text] [Related]
12. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
Schick V; Majores M; Engels G; Spitoni S; Koch A; Elger CE; Simon M; Knobbe C; Blümcke I; Becker AJ
Acta Neuropathol; 2006 Dec; 112(6):715-25. PubMed ID: 17013611
[TBL] [Abstract][Full Text] [Related]
13. Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.
Schick V; Majores M; Koch A; Elger CE; Schramm J; Urbach H; Becker AJ
Epilepsia; 2007; 48 Suppl 5():65-73. PubMed ID: 17910583
[TBL] [Abstract][Full Text] [Related]
14. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
[TBL] [Abstract][Full Text] [Related]
15. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.
Peponi E; Drakos E; Reyes G; Leventaki V; Rassidakis GZ; Medeiros LJ
Am J Pathol; 2006 Dec; 169(6):2171-80. PubMed ID: 17148679
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
[TBL] [Abstract][Full Text] [Related]
17. mTOR pathway activation in focal cortical dysplasia.
Kumari K; Sharma MC; Kakkar A; Malgulwar PB; Pathak P; Suri V; Sarkar C; Chandra SP; Faruq M
Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
[TBL] [Abstract][Full Text] [Related]
18. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
Mizuguchi M; Yamanouchi H; Becker LE; Itoh M; Takashima S
Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
[TBL] [Abstract][Full Text] [Related]
19. Similar PDK1-AKT-mTOR pathway activation in balloon cells and dysmorphic neurons of type II focal cortical dysplasia with refractory epilepsy.
Lin YX; Lin K; Kang DZ; Liu XX; Wang XF; Zheng SF; Yu LH; Lin ZY
Epilepsy Res; 2015 May; 112():137-49. PubMed ID: 25847349
[TBL] [Abstract][Full Text] [Related]
20. Role of the PI3K/Akt, mTOR, and STK11/LKB1 pathways in the tumorigenesis of sclerosing hemangioma of the lung.
Amin RM; Hiroshima K; Miyagi Y; Kokubo T; Hoshi K; Fujisawa T; Nakatani Y
Pathol Int; 2008 Jan; 58(1):38-44. PubMed ID: 18067639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
